The Vanguard Group 13D and 13G filings for TG Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 1:34 pm Sale | 2026-03-13 | 13G | TG Therapeutics, Inc. TGTX | The Vanguard Group | 0 0.000% | -15,596,480 (Position Closed) | Filing |
| 2025-01-08 11:29 am Purchase | 2024-12-31 | 13G | TG Therapeutics, Inc. TGTX | The Vanguard Group | 15,596,480 10.010% | 15,596,480 (New Position) | Filing |